Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of AK102 in patients with hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• AK102

Snippet

Sponsor: Akeso | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED